These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 32290400)
1. Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms. Cerda JR; Arifi T; Ayyoubi S; Knief P; Ballesteros MP; Keeble W; Barbu E; Healy AM; Lalatsa A; Serrano DR Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32290400 [TBL] [Abstract][Full Text] [Related]
2. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms. Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280 [TBL] [Abstract][Full Text] [Related]
3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
4. Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets. Sánchez-Guirales SA; Jurado N; Kara A; Lalatsa A; Serrano DR Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683875 [TBL] [Abstract][Full Text] [Related]
5. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
6. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related]
7. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
8. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery. Tan DK; Maniruzzaman M; Nokhodchi A Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
10. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957 [TBL] [Abstract][Full Text] [Related]
11. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134 [TBL] [Abstract][Full Text] [Related]
12. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution. Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418 [TBL] [Abstract][Full Text] [Related]
13. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925 [TBL] [Abstract][Full Text] [Related]
14. A Low-Cost Method to Prepare Biocompatible Filaments with Enhanced Physico-Mechanical Properties for FDM 3D Printing. Tan DK; Münzenrieder N; Maniruzzaman M; Nokhodchi A Curr Drug Deliv; 2021; 18(6):700-711. PubMed ID: 33155909 [TBL] [Abstract][Full Text] [Related]
15. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Korte C; Quodbach J Pharm Dev Technol; 2018 Dec; 23(10):1117-1127. PubMed ID: 29368974 [TBL] [Abstract][Full Text] [Related]
16. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471 [TBL] [Abstract][Full Text] [Related]
17. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
18. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674 [TBL] [Abstract][Full Text] [Related]
19. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies. Ibrahim M; Barnes M; McMillin R; Cook DW; Smith S; Halquist M; Wijesinghe D; Roper TD AAPS PharmSciTech; 2019 May; 20(5):195. PubMed ID: 31119403 [TBL] [Abstract][Full Text] [Related]
20. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight. Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]